MedTrace Logo

Accuracy of the New Barrett TAL Formula With the Argos Measurements: A Multicenter Prospective Study

NCT06085131 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 501

Last updated 2025-01-30

No results posted yet for this study

Summary

This study is a prospective, multi-site, multi-surgeon, observational study of refractive accuracy with the Argos using BTAL after successful cataract surgery. Subjects will be assessed pre-operatively, operatively and at 5-8 weeks postoperatively. Clinical evaluations will include measurement of visual acuity, manifest refraction, and preoperative biometry.

Conditions

  • Cataract

Interventions

DEVICE

Argos

Argos Biometer

Sponsors & Collaborators

  • Sengi

    collaborator INDUSTRY

  • Shammas Eye Medical Center

    lead OTHER

Principal Investigators

  • H J Shammas, MD · Shammes Eye Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-31
Primary Completion
2025-01-29
Completion
2025-01-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06085131 on ClinicalTrials.gov